Low levels of <scp>anti–SARS–CoV</scp> ‐2 antibodies after vaccination in rituximab‐treated patients: comment on the article by Simon et al

Authors :: Gerasimos Evangelatos
Antigoni Lekka
Alexios Iliopoulos
Maria Triantafylli
George E Fragoulis
Konstantina Kouna
Melina Moschopoulou
Source :: Arthritis & Rheumatology (Hoboken, N.j.)
Publication Year :: 2022
Publisher :: Wiley, 2022.

Subjects :: 2019-20 coronavirus outbreak
biology
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Virology
Vaccination
Rheumatology
biology.protein
Immunology and Allergy
Medicine
Rituximab
Antibody
Letters to the Editor
business
Letter to the Editor
medicine.drug

Tools